Literature DB >> 22284159

Utilizing placebo mechanisms for dose reduction in pharmacotherapy.

Bettina K Doering1, Winfried Rief.   

Abstract

The knowledge and systematic application of the placebo effect remains limited, although its importance to the treatment of various medical conditions has increasingly been recognized. A possible application of the placebo effect to pharmacotherapy is seen in conditioning processes that aim at a placebo-controlled dose reduction of drugs while maintaining the efficacy of the medical treatment. The pairing of a placebo and a pharmacological agent may achieve satisfactory treatment outcomes in combination with a lower dose of medication. This procedure includes classic and instrumental conditioning processes that involve both conscious and non-conscious information processing. Although recent studies have gathered preliminary evidence for the efficacy of placebo-controlled dose reduction (e.g. in psoriasis and attention deficit hyperactivity disorder [ADHD]), they have also illustrated the difficulties that are inherent to this approach. We critically review previous approaches and discuss designs for clinical trials that seem appropriate to the investigation of conditioned placebo effects in pharmacotherapy. Copyright Â
© 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22284159     DOI: 10.1016/j.tips.2011.12.001

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  27 in total

Review 1.  The placebo response in medicine: minimize, maximize or personalize?

Authors:  Paul Enck; Ulrike Bingel; Manfred Schedlowski; Winfried Rief
Journal:  Nat Rev Drug Discov       Date:  2013-03       Impact factor: 84.694

Review 2.  Pain and placebo in pediatrics: a comprehensive review of laboratory and clinical findings.

Authors:  Kanesha Simmons; Robin Ortiz; Joe Kossowsky; Peter Krummenacher; Christian Grillon; Daniel Pine; Luana Colloca
Journal:  Pain       Date:  2014-08-29       Impact factor: 6.961

3.  Partial reinforcement, extinction, and placebo analgesia.

Authors:  Siu Tsin Au Yeung; Ben Colagiuri; Peter F Lovibond; Luana Colloca
Journal:  Pain       Date:  2014-03-03       Impact factor: 6.961

Review 4.  Placebo analgesia: clinical applications.

Authors:  Regine Klinger; Luana Colloca; Ulrike Bingel; Herta Flor
Journal:  Pain       Date:  2013-12-11       Impact factor: 6.961

5.  Nonconscious activation of placebo and nocebo pain responses.

Authors:  Karin B Jensen; Ted J Kaptchuk; Irving Kirsch; Jacqueline Raicek; Kara M Lindstrom; Chantal Berna; Randy L Gollub; Martin Ingvar; Jian Kong
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-10       Impact factor: 11.205

6.  Failure of Placebo Analgesia Model in Rats with Inflammatory Pain.

Authors:  Xiang-Sha Yin; Jin-Yu Yang; Shuai Cao; Yun Wang
Journal:  Neurosci Bull       Date:  2019-08-21       Impact factor: 5.203

7.  Effect of Placebo Conditions on Polysomnographic Parameters in Primary Insomnia: A Meta-Analysis.

Authors:  Alexander Winkler; Winfried Rief
Journal:  Sleep       Date:  2015-06-01       Impact factor: 5.849

8.  Prior experience with a pain stimulus as a predictor of placebo analgesia.

Authors:  Andrew L Geers; Stephanie L Fowler; Justin A Wellman; Suzanne G Helfer; Shane Close; Christopher R France
Journal:  J Behav Med       Date:  2014-07-24

Review 9.  Placebo and the new physiology of the doctor-patient relationship.

Authors:  Fabrizio Benedetti
Journal:  Physiol Rev       Date:  2013-07       Impact factor: 37.312

Review 10.  Learned immunosuppression: extinction, renewal, and the challenge of reconsolidation.

Authors:  Martin Hadamitzky; Harald Engler; Manfred Schedlowski
Journal:  J Neuroimmune Pharmacol       Date:  2012-07-13       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.